Global Intravenous (IV) Solutions Market Research Report 2023
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Peripheral Parenteral Nutrition
1.2.3 Total Parenteral Nutrition
1.3 Market by Application
1.3.1 Global Intravenous (IV) Solutions Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital & Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intravenous (IV) Solutions Market Perspective (2018-2029)
2.2 Intravenous (IV) Solutions Growth Trends by Region
2.2.1 Global Intravenous (IV) Solutions Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Intravenous (IV) Solutions Historic Market Size by Region (2018-2023)
2.2.3 Intravenous (IV) Solutions Forecasted Market Size by Region (2024-2029)
2.3 Intravenous (IV) Solutions Market Dynamics
2.3.1 Intravenous (IV) Solutions Industry Trends
2.3.2 Intravenous (IV) Solutions Market Drivers
2.3.3 Intravenous (IV) Solutions Market Challenges
2.3.4 Intravenous (IV) Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intravenous (IV) Solutions Players by Revenue
3.1.1 Global Top Intravenous (IV) Solutions Players by Revenue (2018-2023)
3.1.2 Global Intravenous (IV) Solutions Revenue Market Share by Players (2018-2023)
3.2 Global Intravenous (IV) Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intravenous (IV) Solutions Revenue
3.4 Global Intravenous (IV) Solutions Market Concentration Ratio
3.4.1 Global Intravenous (IV) Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Solutions Revenue in 2022
3.5 Intravenous (IV) Solutions Key Players Head office and Area Served
3.6 Key Players Intravenous (IV) Solutions Product Solution and Service
3.7 Date of Enter into Intravenous (IV) Solutions Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intravenous (IV) Solutions Breakdown Data by Type
4.1 Global Intravenous (IV) Solutions Historic Market Size by Type (2018-2023)
4.2 Global Intravenous (IV) Solutions Forecasted Market Size by Type (2024-2029)
5 Intravenous (IV) Solutions Breakdown Data by Application
5.1 Global Intravenous (IV) Solutions Historic Market Size by Application (2018-2023)
5.2 Global Intravenous (IV) Solutions Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Intravenous (IV) Solutions Market Size (2018-2029)
6.2 North America Intravenous (IV) Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Intravenous (IV) Solutions Market Size by Country (2018-2023)
6.4 North America Intravenous (IV) Solutions Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intravenous (IV) Solutions Market Size (2018-2029)
7.2 Europe Intravenous (IV) Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Intravenous (IV) Solutions Market Size by Country (2018-2023)
7.4 Europe Intravenous (IV) Solutions Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intravenous (IV) Solutions Market Size (2018-2029)
8.2 Asia-Pacific Intravenous (IV) Solutions Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2018-2023)
8.4 Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intravenous (IV) Solutions Market Size (2018-2029)
9.2 Latin America Intravenous (IV) Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Intravenous (IV) Solutions Market Size by Country (2018-2023)
9.4 Latin America Intravenous (IV) Solutions Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intravenous (IV) Solutions Market Size (2018-2029)
10.2 Middle East & Africa Intravenous (IV) Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2018-2023)
10.4 Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICU Medical Inc. (U.S.)
11.1.1 ICU Medical Inc. (U.S.) Company Detail
11.1.2 ICU Medical Inc. (U.S.) Business Overview
11.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Introduction
11.1.4 ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.1.5 ICU Medical Inc. (U.S.) Recent Development
11.2 B. Braun Melsungen AG (Germany)
11.2.1 B. Braun Melsungen AG (Germany) Company Detail
11.2.2 B. Braun Melsungen AG (Germany) Business Overview
11.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Introduction
11.2.4 B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.2.5 B. Braun Melsungen AG (Germany) Recent Development
11.3 Fresenius Kabi AG (Germany)
11.3.1 Fresenius Kabi AG (Germany) Company Detail
11.3.2 Fresenius Kabi AG (Germany) Business Overview
11.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Introduction
11.3.4 Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.3.5 Fresenius Kabi AG (Germany) Recent Development
11.4 Baxter (U.S.)
11.4.1 Baxter (U.S.) Company Detail
11.4.2 Baxter (U.S.) Business Overview
11.4.3 Baxter (U.S.) Intravenous (IV) Solutions Introduction
11.4.4 Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.4.5 Baxter (U.S.) Recent Development
11.5 Amanta Healthcare (India)
11.5.1 Amanta Healthcare (India) Company Detail
11.5.2 Amanta Healthcare (India) Business Overview
11.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Introduction
11.5.4 Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.5.5 Amanta Healthcare (India) Recent Development
11.6 Terumo Medical Corporation (Tokyo)
11.6.1 Terumo Medical Corporation (Tokyo) Company Detail
11.6.2 Terumo Medical Corporation (Tokyo) Business Overview
11.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Introduction
11.6.4 Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.6.5 Terumo Medical Corporation (Tokyo) Recent Development
11.7 Grifols S.A. (Spain)
11.7.1 Grifols S.A. (Spain) Company Detail
11.7.2 Grifols S.A. (Spain) Business Overview
11.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Introduction
11.7.4 Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.7.5 Grifols S.A. (Spain) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Intravenous (IV) Solutions Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Peripheral Parenteral Nutrition
Table 3. Key Players of Total Parenteral Nutrition
Table 4. Global Intravenous (IV) Solutions Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Intravenous (IV) Solutions Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Intravenous (IV) Solutions Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Intravenous (IV) Solutions Market Share by Region (2018-2023)
Table 8. Global Intravenous (IV) Solutions Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Intravenous (IV) Solutions Market Share by Region (2024-2029)
Table 10. Intravenous (IV) Solutions Market Trends
Table 11. Intravenous (IV) Solutions Market Drivers
Table 12. Intravenous (IV) Solutions Market Challenges
Table 13. Intravenous (IV) Solutions Market Restraints
Table 14. Global Intravenous (IV) Solutions Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Intravenous (IV) Solutions Market Share by Players (2018-2023)
Table 16. Global Top Intravenous (IV) Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solutions as of 2022)
Table 17. Ranking of Global Top Intravenous (IV) Solutions Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Intravenous (IV) Solutions Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Intravenous (IV) Solutions Product Solution and Service
Table 21. Date of Enter into Intravenous (IV) Solutions Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Intravenous (IV) Solutions Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Intravenous (IV) Solutions Revenue Market Share by Type (2018-2023)
Table 25. Global Intravenous (IV) Solutions Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Intravenous (IV) Solutions Revenue Market Share by Type (2024-2029)
Table 27. Global Intravenous (IV) Solutions Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Intravenous (IV) Solutions Revenue Market Share by Application (2018-2023)
Table 29. Global Intravenous (IV) Solutions Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Intravenous (IV) Solutions Revenue Market Share by Application (2024-2029)
Table 31. North America Intravenous (IV) Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Intravenous (IV) Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Intravenous (IV) Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Intravenous (IV) Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Intravenous (IV) Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Intravenous (IV) Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Intravenous (IV) Solutions Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Intravenous (IV) Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Intravenous (IV) Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Intravenous (IV) Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Intravenous (IV) Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 46. ICU Medical Inc. (U.S.) Company Detail
Table 47. ICU Medical Inc. (U.S.) Business Overview
Table 48. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product
Table 49. ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 50. ICU Medical Inc. (U.S.) Recent Development
Table 51. B. Braun Melsungen AG (Germany) Company Detail
Table 52. B. Braun Melsungen AG (Germany) Business Overview
Table 53. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product
Table 54. B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 55. B. Braun Melsungen AG (Germany) Recent Development
Table 56. Fresenius Kabi AG (Germany) Company Detail
Table 57. Fresenius Kabi AG (Germany) Business Overview
Table 58. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product
Table 59. Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 60. Fresenius Kabi AG (Germany) Recent Development
Table 61. Baxter (U.S.) Company Detail
Table 62. Baxter (U.S.) Business Overview
Table 63. Baxter (U.S.) Intravenous (IV) Solutions Product
Table 64. Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 65. Baxter (U.S.) Recent Development
Table 66. Amanta Healthcare (India) Company Detail
Table 67. Amanta Healthcare (India) Business Overview
Table 68. Amanta Healthcare (India) Intravenous (IV) Solutions Product
Table 69. Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 70. Amanta Healthcare (India) Recent Development
Table 71. Terumo Medical Corporation (Tokyo) Company Detail
Table 72. Terumo Medical Corporation (Tokyo) Business Overview
Table 73. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product
Table 74. Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 75. Terumo Medical Corporation (Tokyo) Recent Development
Table 76. Grifols S.A. (Spain) Company Detail
Table 77. Grifols S.A. (Spain) Business Overview
Table 78. Grifols S.A. (Spain) Intravenous (IV) Solutions Product
Table 79. Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 80. Grifols S.A. (Spain) Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Intravenous (IV) Solutions Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Intravenous (IV) Solutions Market Share by Type: 2022 VS 2029
Figure 3. Peripheral Parenteral Nutrition Features
Figure 4. Total Parenteral Nutrition Features
Figure 5. Global Intravenous (IV) Solutions Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Intravenous (IV) Solutions Market Share by Application: 2022 VS 2029
Figure 7. Hospital & Clinics Case Studies
Figure 8. Ambulatory Case Studies
Figure 9. Home Care Case Studies
Figure 10. Intravenous (IV) Solutions Report Years Considered
Figure 11. Global Intravenous (IV) Solutions Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Intravenous (IV) Solutions Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Intravenous (IV) Solutions Market Share by Region: 2022 VS 2029
Figure 14. Global Intravenous (IV) Solutions Market Share by Players in 2022
Figure 15. Global Top Intravenous (IV) Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solutions as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Intravenous (IV) Solutions Revenue in 2022
Figure 17. North America Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Intravenous (IV) Solutions Market Share by Country (2018-2029)
Figure 19. United States Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Intravenous (IV) Solutions Market Share by Country (2018-2029)
Figure 23. Germany Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Intravenous (IV) Solutions Market Share by Region (2018-2029)
Figure 31. China Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Intravenous (IV) Solutions Market Share by Country (2018-2029)
Figure 39. Mexico Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Intravenous (IV) Solutions Market Share by Country (2018-2029)
Figure 43. Turkey Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. ICU Medical Inc. (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 46. B. Braun Melsungen AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 47. Fresenius Kabi AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 48. Baxter (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 49. Amanta Healthcare (India) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 50. Terumo Medical Corporation (Tokyo) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 51. Grifols S.A. (Spain) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed